REMINDER: Our user survey closes on Friday, please submit your responses here.
There have been further ENSI sales referenced in the last couple of updates. I would say now total holding around 900k shares. Buys were at 42.5p & 70p and Sale prices have been as high as ~90p hence why the breakeven is now relatively low. Overall in good profit on this one.
Agree @THG
In the news!
https://www.cityam.com/investors-in-london-listed-medical-tech-firm-continue-battle-to-oust-top-brass/
Agree that the portfolio is beginning to look a little more interesting with many off their lows. I reckon there are probably 5 shares that need to be got rid off which may also help with the overall value perception.
After some trades, I think current holding is 595,902 @ 58p (unless some sold since last qtr)
Did you pick up on the recent RNS announcing a name change to Finseta (FIN)
https://www.lse.co.uk/rns/CSFS/proposed-change-of-name-to-finseta-plc-il46nlbddq5vrwv.html
& therein lies the problem. As mentioned previously, there are no consequences for their actions. The Directors are not answerable to anyone but themselves. They will continue to extract £5k cash each, each and every month for the foreseeable future (years?) by whatever means available.
@BouncersDream, I would agree with your sentiment that "AIM / small cap market being a bad place to hold long term". However that is the Vela Business Model and they have stated they will continue with that strategy. So even if CDT pumps a little and there is a cash out, then what next? What would be the point of just re-investing back into AIM/Aquis?
Anticipation and expectation that the combined net value of the investee companies will substantially increase. If the market thought CDT SP would rise to $5 in the near term, thereby enabling Vela to at least partially cash out, the SP would rise with no RNS.
What are your thoughts on this?